-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 27, Pien Tze Huang issued an announcement stating that LDS tablets, a research and development project in cooperation with Lidao Pharmaceutical, received the "Notice of Drug Clinical Trial Approval" issued by the State Drug Administration
LDS tablets are mainly used for the treatment of fibromyalgia, and clinical trials need to be carried out and reviewed by the National Medical Products Administration, before they can be produced and marketed
The receipt of the "Notice of Approval of Drug Clinical Trials" will have no significant impact on the company's financial status and operating results this year